Valuation: Seer, Inc.

Market Cap 103M 89.81M 84.8M 77.01M 144M 9.88B 145M 1.02B 392M 5.02B 387M 378M 16.17B P/E 2026 *
-1.69x
P/E 2027 * -1.82x
Enterprise Value 103M 89.81M 84.8M 77.01M 144M 9.88B 145M 1.02B 392M 5.02B 387M 378M 16.17B EV / Sales 2026 *
6.4x
EV / Sales 2027 * 5.31x
Free-Float
85.35%
Yield 2026 *
-
Yield 2027 * -
1 day-3.13%
1 week-4.62%
Current month-5.10%
1 month-7.92%
3 months+6.90%
6 months+6.90%
Current year+1.64%
1 week 1.84
Extreme 1.84
1.94
1 month 1.84
Extreme 1.84
2.08
Current year 1.55
Extreme 1.55
2.34
1 year 1.55
Extreme 1.55
2.41
3 years 1.46
Extreme 1.455
2.62
5 years 1.46
Extreme 1.455
38.87
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 01/03/2018
Director of Finance/CFO 58 01/05/2020
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 01/09/2020
Director/Board Member 76 01/12/2017
Director/Board Member 70 01/12/2017
Date Insider Type Main position Quantity % Market Cap. Importance
18/08/26 Sell

Chief Financial Officer

-7,309 0.0132%
28/07/26 Free

Director

41,500 0.0750%
28/07/26 Free

Director

41,500 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
-3.12%-4.62%-15.45%-22.50% 103M
-1.28%+7.64%+8.17%+22.67% 27.9B
+1.21%+4.97%+5.36%-5.35% 7.23B
+3.38%+14.58%+2.33%+109.78% 3.55B
0.00%+9.95%+38.04%-31.50% 3.27B
+2.08%+5.95%+48.80%+51.79% 2.25B
+2.27%+8.85%+25.54%+52.66% 1.87B
+2.96%+10.06%-5.05%+32.19% 1.87B
-2.89%0.00%-6.49%+44.83% 1.26B
+2.90%+4.76%-32.63%-22.29% 843M
Average +0.75%+5.71%+6.86%+23.23% 5.02B
Weighted average by Cap. -0.04%+7.51%+10.18%+23.76%

Financials

2026 *2027 *
Net sales 16.1M 14.04M 13.26M 12.04M 22.55M 1.54B 22.65M 159M 61.28M 785M 60.48M 59.14M 2.53B 19.4M 16.92M 15.97M 14.5M 27.18M 1.86B 27.29M 191M 73.84M 946M 72.88M 71.26M 3.05B
Net income -61.2M -53.37M -50.39M -45.76M -85.73M -5.87B -86.09M -604M -233M -2.99B -230M -225M -9.61B -57.7M -50.31M -47.51M -43.14M -80.83M -5.54B -81.17M -569M -220M -2.81B -217M -212M -9.06B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
18/09/26 $1.860 -3.12% 563,370
17/09/26 $1.920 +1.05% 212,272
16/09/26 $1.900 0.00% 147,245
15/09/26 $1.900 -0.52% 181,450
14/09/26 $1.910 -2.05% 161,270
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.860USD
Average target price
4.000USD
Spread / Average Target
+115.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!